Nuwellis Inc (NASDAQ:NUWE) — Market Cap & Net Worth
Market Cap & Net Worth: Nuwellis Inc (NUWE)
Nuwellis Inc (NASDAQ:NUWE) has a market capitalization of $1.57 Million ($1.57 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30210 globally and #6068 in its home market, demonstrating a -20.91% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nuwellis Inc's stock price $1.74 by its total outstanding shares 902665 (902.66K). Review debt load of Nuwellis Inc to assess the company's total debt and financial obligations.
Nuwellis Inc Market Cap History: 2015 to 2026
Nuwellis Inc's market capitalization history from 2015 to 2026. Data shows change from $902.66 Billion to $1.57 Million (-70.75% CAGR).
Index Memberships
Nuwellis Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #891 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2830 of 3165 |
Weight: Nuwellis Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nuwellis Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nuwellis Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
Nuwellis Inc's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $902.66 Billion | $59.00K | -$26.58 Million | 15299406.78x | N/A |
| 2016 | $902.66 Billion | $1.29 Million | -$15.79 Million | 700283.17x | N/A |
| 2017 | $902.66 Billion | $3.55 Million | -$13.38 Million | 254057.13x | N/A |
| 2018 | $647.80 Billion | $5.00 Million | -$17.03 Million | 129611.94x | N/A |
| 2019 | $81.62 Billion | $5.51 Million | -$18.11 Million | 14811.17x | N/A |
| 2020 | $22.02 Billion | $7.44 Million | -$15.84 Million | 2959.35x | N/A |
| 2021 | $3.60 Billion | $7.92 Million | -$19.55 Million | 454.69x | N/A |
| 2022 | $338.68 Million | $8.54 Million | -$14.53 Million | 39.64x | N/A |
| 2023 | $18.35 Million | $8.86 Million | -$20.21 Million | 2.07x | N/A |
| 2024 | $1.00 Million | $8.74 Million | -$11.16 Million | 0.11x | N/A |
Competitor Companies of NUWE by Market Capitalization
Companies near Nuwellis Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Nuwellis Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Nuwellis Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Nuwellis Inc's market cap moved from $902.66 Billion to $ 1.57 Million, with a yearly change of -70.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.57 Million | 0.00% |
| 2025 | $1.57 Million | +56.76% |
| 2024 | $1.00 Million | -94.54% |
| 2023 | $18.35 Million | -94.58% |
| 2022 | $338.68 Million | -90.60% |
| 2021 | $3.60 Billion | -83.64% |
| 2020 | $22.02 Billion | -73.02% |
| 2019 | $81.62 Billion | -87.40% |
| 2018 | $647.80 Billion | -28.23% |
| 2017 | $902.66 Billion | 0.00% |
| 2016 | $902.66 Billion | 0.00% |
| 2015 | $902.66 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Nuwellis Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.57 Million USD |
| MoneyControl | $1.57 Million USD |
| MarketWatch | $1.57 Million USD |
| marketcap.company | $1.57 Million USD |
| Reuters | $1.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The compan… Read more